- Report
- January 2026
- 274 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 178 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 390 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 138 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 294 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 370 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 401 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 479 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 272 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 294 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 271 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 282 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 473 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 383 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 464 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 383 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 217 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 468 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 291 Pages
Global
From €5120EUR$5,850USD£4,437GBP
- Report
- January 2026
- 242 Pages
Global
From €5120EUR$5,850USD£4,437GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more